These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 8894432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
    Jarratt M, Jones T, Adelglass J, Bucko A, Pollak R, Roman-Miranda A, Olin JT, Swinyer L.
    J Drugs Dermatol; 2014 Jul; 13(7):838-46. PubMed ID: 25007368
    [Abstract] [Full Text] [Related]

  • 5. Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis.
    Pariser DM, Pariser RJ.
    Cutis; 1994 Jul; 54(1):43-4. PubMed ID: 7924451
    [Abstract] [Full Text] [Related]

  • 6. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF, Vlahovic T, Verma A, Olayinka B, Fleischer AB.
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF, Parish LC, Vlahovic T, Plaum S, Kircik L, Fleischer AB, Verma A, Olayinka B, Hardas B.
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [Abstract] [Full Text] [Related]

  • 8. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
    Watanabe S, Takahashi H, Nishikawa T, Takiuchi I, Higashi N, Nishimoto K, Kagawa S, Yamaguchi H, Ogawa H.
    Mycoses; 2007 Jan; 50(1):35-40. PubMed ID: 17302746
    [Abstract] [Full Text] [Related]

  • 9. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
    Elewski BE, Vlahovic TC.
    J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
    [Abstract] [Full Text] [Related]

  • 10. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
    Jegasothy BV, Pakes GE.
    Clin Ther; 1991 Jul; 13(1):126-41. PubMed ID: 2029718
    [Abstract] [Full Text] [Related]

  • 11. Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study.
    Jarratt M, Jones T, Kempers S, Rich P, Morton K, Nakamura N, Tavakkol A.
    Cutis; 2013 Apr; 91(4):203-10. PubMed ID: 23763082
    [Abstract] [Full Text] [Related]

  • 12. The use of 40% urea cream in the treatment of moccasin tinea pedis.
    Elewski BE, Haley HR, Robbins CM.
    Cutis; 2004 May; 73(5):355-7. PubMed ID: 15186053
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK, Skinner AR, Cooper EA.
    Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
    [Abstract] [Full Text] [Related]

  • 14. [Fundamental and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 2. Clinical evaluation].
    Watanabe S, Takahashi H, Nakamura Y, Nakamura E, Nishiyama Y, Teduka M, Yamaguchi H, Uchida K, Tomizawa T, Shimozuma M, Osada A, Kawano S, Nakauchi Y, Wakukawa M, Goto A, Ueda Y, Matsukawa A, Minami H, Arikawa J, Soma Y, Chi HI, Tamaki K.
    Jpn J Antibiot; 1996 Dec; 49(12):1095-108. PubMed ID: 9032596
    [Abstract] [Full Text] [Related]

  • 15. Topical sertaconazole (ertaczo)--another azole for tinea pedis.
    Med Lett Drugs Ther; 2004 Jun 21; 46(1185):50-1. PubMed ID: 15211288
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E.
    J Eur Acad Dermatol Venereol; 2006 Nov 21; 20(10):1307-13. PubMed ID: 17062050
    [Abstract] [Full Text] [Related]

  • 18. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R, De Villez RL, Elewski B, Hong S, Jones T, Lowe N, Lucky A, Reyes B, Stewart D, Willis I.
    J Am Acad Dermatol; 1997 Feb 21; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of "tinea pedis" with griseofulvin and topical antifungal cream.
    Zaias N, Battistini F, Gomez-Urcuyo F, Rojas RF, Ricart R.
    Cutis; 1978 Aug 21; 22(2):197-9. PubMed ID: 688767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.